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m1075116 EndovsscularAbdominalAorticAnauryamRepairinHighRiskSurgicalPatienta:Acuts
Outcoms
G. Dorms, A. Parikh, R. Sehgal, J. Crouch. St. Luke’s Medical CenfeL
Milwaukee, W/, USA
Endovascular abdominal aortic aneurysm (AAA) repair was performed in
39 patients (pts) (mean age 72 + 8 yeare) with an anticipated prohibitively
high surgical risk (? 50%), employing a stent-graft to assess if this technique
were a therapeutic alternative to bypass surgery.The stent-graft successfully
excluded the aneurysm m 36 (92%) pts; and, 3 pts (8%) required emergency
bypass surgery because of inability to place the device. Periprocedural com-
plications included 3 deaths (6%), 4 pts (10%) having sepsis, 10 pts (25%)
having atheroemboli, 10 pte (25%) developing acute renal failure, and 24 pts
(60%) having a fever of unknown origin (which resolved within 72 hours).
Blood transfusions were required in 29 pts (73%). Prior to hospital discharge,
all 36 successful stent deployment pts had undergone imaging (38 post prc-
cedure angiograms, and 12 spiral CT scans) which revealed 7 pts (19%) with
a small endcgraft leak. Thirty-three of the 36 stent deployment pts were dis-
charged, improved, with an excluded aneurysm. Conclusion.’Endovascular
repair can successfully exclude an abdominal aortic aneurysm using a stent-
graft in high-risk surgicel pte, and appears, despite its notnegligible morbidity
and mortality, even at this early stage of its technologic development, to be
an alternative to bypass surge~.
m1075117 PrimaryEndoluminalStentingfortheTreatment
ofComplexIliacArteryLesions
R. Corti, A. Crivelli, M. Alerci, A. Gallino. Division ofcardiobgy, Ospeda/e
San Giovanni, 6500 Be//inzona, SwL!zer/and
Endovascular stenting (S) has been used as a secondaty procedure in
cases of primary failure following angioplasfy of peripheral arteries. We
report the results of our experience with primary S of iliac artery lesions in
54 patients (pts) who underwent 64 procedures using an autoexpandable
Wallstent. All pts present with claudicatio 11Aor B, ABI at rest and after
standardized effort was 0.82 * 0.19 and 0.52 * 0.30. Angiographic lesions
consist of compiete occlusion of the common (14) or external (10) iliac
artery and of complex stenosis of the common (19) or external (21) iliac
artery. Follow-up (3.6 & 2.2 months) included clinical assessment, ABI at
rest and after standardized effort; high definition transcutanwus vascular
echography (HDE) couldbe obtainedin 44 pts. Primary success rate was
1007. with complete recanalisation of the occluded vessels and < 30%
residual stenosis. Early reocclusion occurred in 5 pts and was successfully
managed by secondary angioplasty. At follow-up 49/54 pts complained of no
symptoms, ABI at rest and after effott was 1.1 + 0.13 and 0.89+ 0.20 (both
p <0.01 vs pre-stent values). HDE showed significant restenosis in 13/64
procedures (20%). Primaty S seems to be a valid therapeutical modality for
pts with complex iliac artety lesions.
m1075135 Stentingof ChronicallyOccludedSuperficialFamoralArteriesUsingPalmszBiliaryStante
SignificantlyImprovesLongTermPatency
T.A. Biggs, W.C. Daniel, D. Hallas, P. Eikenberry, M.J. Pirwitz, S.B. Laster,
T.M. Shimshak. Mid-America Haart /nstitute, St. Luke’s /-fospita/,Kansas
Ci~ MO, USA
The purpose of this atudy is to compare the iong term patency of chronically
occluded superficial femoral arteries (SFA) following percutaneous translu-
minal angiopleety (PTA) alone vs. PTA and stenting of the primary lesion
with a Palmsz biliary stent. We reviewed a consecutive series of patients
in our PTA database and identified 39 patients with a chronically occluded
SFA who were successfully revascularized with percutaneous techniques.
20 of the patients were treated with PTA alone and the remaining 19 also
had a stent placed at the site of what was felt to be the “culprit lesion”
within the SFA. The two groups ware similar in regard to smoking frequency,
percentage of men, extent of atherosclerotic disaase, and frequency of lipid
abnormalities.
Mean long term follow-up was 10 + 4 months for the group treated
with PTA alone and 11 + 3 months for those who received stents. Clinical
antior angiographic restanosis occurred in 12 of 20 (60%) patients in the
conventional angioplaaty group and in only 4 of 19 (21%) in the Pa/maz
biliarystentgroup (p = 0.02).
Cone/usion:Although patients with chronically occluded superficial femorel
arteries have a high reocciusion rata following conventional percutaneous
balloon angioplasty, the deployment of Palmez biliary stents at the aite of the
primary lesion within the SFA appears to significantly improve the long term
patency.
11075-136] RaCOnatruCtiOnofLongTotilSupetiicisl
FemoralArteryOcclusionsUaingMultipleWall
Stents
A. Pathan, M. Ganim, P.Wong, K. Fujise, E. Rojas, M. Revana,
H.V.Anderson, G.W. Schroth, R.W. Smalling. University of TexaaMadica/
School, Harmann Hoapital, Houston, TX, USA
Long term outmme of Wall stent (WS) placement in totally occluded’euperfi-
cial femoral arteries (TOSFA) is unknown. In 22 patients with WS placement
for superficial femoral artery occlusive disease, we compared the clinical
outcome in 13 arteries stented for TOSFA to 12 arteries stented for par-
tially occluded superficial femoral arteries (POSFA). Baseline clinical and
angiographic characteristics (age, the presence of diabetes mellitus, history
of tobacco use and the number and quality of patent runoff vessels) were
similar in both groups (p >0.7 for all). The average length of diseased vesael
segment was 10.5 + 7.0 cm in the TOSFA group and was 15.5 + 7.7 cm in
the POSFA group. The procedural success rate was 100% in both groups
with a major complication rate of 8%. Tha number of stents placed were sim-
ilar in both groups (TOSFA = 2.34 vs POSFA = 2, p > 2.0). All but 2 patients
received oral anticoegulation (warfarin) in addition to antiplatelet therapy (as-
pirin). During a mean follow-up of 7.1 + 4.4 months, 77.6% of TOSFA and
57% of pCISFAhad less claudication as assessed by at leaSt a One wade
increase in Fontaine class (p > 0.4). Twenty percant of patients required
repeat percutaneous revascularization for symptomatic recurrence and 6%
requiredperipheral bypass surgery. Cone/usion:WS placement is technically
feasible in the presence of long segment TOSFA. The long term clinical
outcome is also favorable when compared to WS placement for POSFA.
WI RatrogradePoplitsalStentingofChronicTotal
Occlusionsin FailedAntearadeAnaionlaatv:
Demonstrationof lmprove~Prima&Sicce&
and Limited Long-Term Benefit
T.K. Bajwa, Y. Shalev, D.H. Schmidt. Mi/waukee Heart hrstitute,
Cardiovascular Disaaae Consultants, Milwaukee, WI, uSA
in 50 patients with chronic total femoral arte~ occlusions (CTO) failing con-
ventional antegrade femoral recanalization (AFR), the new technique of ret-
rograde popliteal stenting (RPS) was utilized in 74 CTOS.Terumo wire waa
used to cross the CTOS, followed by balloon angioplasty and subsequent
deployment of wall stent using an 8 French sheath. Mean study group age
was 65 + 5 yaam (40 males, 10 females). All 50 patients had claudication
(< 2 blocks) and 6 had rest pain with ischemic ulcers. Ankle-branchial in-
dicea (ABI) were done pre- and post-RPS. One patient developad popliteal
hematoma which needed surgical repair. Six-month angiogrephic followup
was available in 66/74 (89Yo)limbs at risk: 34/66 (52%) limbs ahowed clinical
and angiographic restenosis needing repeat balloon angioplasty or surgical
revascularization.
Conclusions:
(1)CTO of the femoral artery in patients with failed AFR can be recanalized
by RPS with high primary success.
(2) Complications are low, and long-term symptomatic benefits are limited
by a high restenosis rate.
m1075138, Comparisonof the PslmazStentandWallStantReconstructionof CriticalSubclsvisnArtery
Stenosie
A. Pathan, P.Wong, K. Fujise, M. Ganim, M.K. Jeang, J.A. Mullins,
Z. Krejcer,J.V. Benrey, E.C. Perin, G.W. Schroth, R.W. Smalling. University
of TexasMedical School, Hermann Hospital and St. Lukes Hoapital,
Houston, TX, USA
To assess the long term outcome of subclavian artery stenting, we followed
35 patients (17 males, mean age 63 + 8.5 years) with 36 stented arteries
(left-29, right-7; proximal-33, distal-3; total occlusions-6) treated either with
Palmaz stents (PS) (n= 28) or Wall stents (WS) (n =8) over a mean of 14
months (range: 1–38). Presenting symptoms included upper extremity clau-
dication (71.4%), subclavian steal syndrome (34.2%), or angina secondary
to myocardial ischemia in the tarritoy supplied by the ipsilateral LIMA graft
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(31.4%).The meanhospitalstaywas2 A 2 days.Orelanticoagulationwas
givento 25.7%of patients,whileallpatientsreceivedanantiplateletregimen
(aspirinaloneoraspirinandticlopidine).Proceduralsuccessratewea100%
witha majorcomplicationrateof s.i’~o. Follow-upwasavailablein77.7Y0of
patients.Theclinicallyassessedpatencyratewas85.7%andwas92.8%af-
tera seconddilatationfor restenosis.ThepatencyrateforthePSgroupwee
significantlyhigherthanthatof theWSgroup(1007.vs50%,p < 0.01).Oral
anticoagulationdid not changethe longtermpatencyratefor PSor WS(p
> 0.8).Nostent-inducedemboliccerebrovasculareventsoccurred.Concis-
ion: Subclavianarterystentinghasanexcellentlongtermclinicaloutcome
with antiplatelettherapyalone.The procedure-relatedcomplicationrate is
low.PSseemsto havea morefavorableclinicaloutcomewhencomparedto
WS in the subclavian position.
m1075139 RenalDysfunctioniaa PoorPrognosticatorofPatientSurvivalAfterPelmazmStent
Revaacularizetionfor RenalAtieryStanoaia
G. Dorros,M.Jaff,1.Dorros,A. Lowe,L.Mathiak..% Luke’sMedical
CentefiM/lwaukee,Wisconain,USA
Renal artery stenosis(es) (RAS)were successfullyreveecularizadwith
PalmazNstentsin 123 patients(pts) (age:68 + 9 years)for poorlycon-
trolledhypertensionancflorpreservationof renalfunction:47 pts (39%)had
a baselinecreatinine(Cr)s 1.4mg%;31pts (26%)hada Cr 1S-1.9 mg%;
and42pta(35%)hada Crz 2.0mg%.Sixin-hospitaldeathswereunrelated
to the procedureand occurredin ptewithCr z 2.0 mg%.During36 month
followup,22 pte died: 4 to end-stagerenaldisease,10 to cardiovascular
diseases,4 to cancer,and4 ptsto othercauses.Thecohort’ssurvivalprob-
abilitywas79+ 4%.Survivalwasthenasaessadbystratifyingptsaccording
to baselineCr.
BaselineCreatinins (mg%) Survival(36 mos)
5 1,4 97* 2
1.5-1.9 86 k 6
? 2.0 46& 10 (p< 0,0001)
Conclusions:Despitestentrevascularization,RASptshavea70%3 year
survival,withfewdeathsrelatedto endstagerenaldisease.However,renal
dysfunctionpts(Cr22.Omg%)haveonlya46%3yearaurvivalwhichimplies
thatrenaldysfunctionassociatedwithRASisapm’prognosticator.
m1075140 BilateralRenalArteryStenosiacanbeEffectivelyTraatedwithPalmaz’MStent
Revascularizetion
G. Dorros,M.Jaff,L Dorroa,A. Lowe,L. Mathiak.St.Luke’sMedica/
CentecMilwaukee,Wisconsin,USA
Twenty-ninepatients(pte) [meanage 69 + 9 yr%,16 males(55%)]with
bilateralatheroscleroticrenalarteryetenosisweresuccessfullyrevaecular-
izad[49/50(96%)stenoticarteries]withPalmazmstentsforpoorlycontrolled
hypertensionand/orpreservationof renalfunction,andwerefollowd with
regardsystolic(SYST)anddiastolic(DIAST)bloodpresaure(BP)response,
the numberof antihypertensivemedications,creatinine(Cr),and sutvival.
Followupdata in each time intervalwee comparedto the patient’sown
baselinemeasurements(pairedcomparison),so as to determinestatistical
significance(*p < 0.05).
Ss8dine 6 mos. 12 mos. 24 mos. 36 mos
SYSTSP(mmHg) 165+26 156&25 154 *30 141 +26” 139 + 20”
DIAST SP (mmHg) 61 &13 S2* 12 80& 15 78& 10 76 k 7
# Medications 2.3 + 1.3 t,9 * 1.0 1.5* 1.0” 1.6 & 0.7 1.1+0.5”
Crestinine(%) 1.9* 1.0 1.7+0.9 1.7+0.6 1.7* 1.2 1.7+0.6
survival(mg%) - 89*5 69*5 79* 6 53* 16
Conclusions:Stent revascularizationof pts with bilateralrenal artery
etenoses,at 2 and 3 yeareeffectivelyloweredthe syetolicbloodpressure,
andthe numberof medicstiona;whilethecreatinineremainedstable.While
stentamayeffectivelyopenstanoticrenalarteries,theirpresenceappearsto
bea poorprognosticmarker,asexpressedbythe53%3 yearsurvival.
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EpiaodicPulmonaryEdema(CHF)in
AssociationwithGlobalRenalIachemiafrom
RenalArtaryStenosia(RAS):Succeaaful
TreatmentbyRenalAtieryStenting(PTRA)
M.Rajachandran,R.Schainfeld,G.M.Chaudhry,A. Pieczek,L. Haley,
K. Rosenfield.St.E/izabeth’sMedica/Center,TuffsUniversitySchoo/of
Medicine,Boston,MA,USA
Of 72 patientsundergoingPTRA,a subsetof 20 (27%)patientspreeentad
with episodicCHF.12/20 (60%)had “global renal ischemia”,with either
bilateralrenalarterystenosisor a solitaryfunctioningkidneyperfusedby a
stenoticrenalarte~. 13patientahadnormalleftventricularejec4ionfraction
(LVEF)andnosignificantvalvularabnormality,asassessedbytransthorecic
echocardiography.Leftventricularhypertrophywas presentin 12 patienta.
Ofthe12patientswithglobalrenalcompromise,9 hadnormalornearnormal
LVEFbutnonethelessdevelopadacuteCHF.
Resu/ts:Atl 20 patients underwent successful PTRA/Palmaz etent de-
ployment under angiographic and intravascular ultrasound (IVUS) guidance.
Patients had six month clinical follow upand 17/20(65%)hadangiographic,
IVUS,andhemodynamicfollowup.TherewasnorecurrenceofCHFin18/20
(90
pressuredroppedfrom 188+ 30/92+ 14 mmHg to 147+ 18/78+ 11mm
Hg[p= 0.002]at sixmonths,on fewerantihypertensivemedications(3.7+
1.6 reducedto 2.6 + 1.4 [p = 0.005]).In patientswith reducedLVEF,ad-
ministrationof angiotensinconvertingenzymeinhibitora(ACE-1)after renal
PTRAJstentwasnotassociatedwithanydeteriorationof renalfunction.
Corrc/usions.’(l)EpisodicCHF,especiallywithnormalLVEF,mayindicata
the presenceof underlyingrenal atiery stenosia.(2) Patientswith global
renalischemia(bilateralrenalarterystenosisorcompromiaadflowto solitary
functioningkidney)commonlymaypresentas CHF.(3) PTRAwith Palmaz
stentdeploymentis an effectivemeanaof managingCHFassociatedwith
RAS.(4) In presenceof reducedLVEFand RAS,ACE-1is betrertolerated
afterrenalarterystenting.
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\ 1076-58) EffeOtSOf Ramipriiva.HydrOCh,OrOthiazideOn
AmbulatoryBloodPreaeureandLVMasain
PredominantlyNon-WhiteHypertenalvePatients
M.J.Roman,M.H.Alderman,T.G.Pickering,J. Keating,M.O’Grady,
R.B.Devereux.CornellUniversityandAlberTEinsteinCollegeof Medicine,
NewYork,NY USA
Tocomparethe efficacyof ACEinhibitionand diuretictherapyin reducing
blocdpressure(BP)andleftventricular(LV)mass,50essentialhypertensive
(74% male, 88% non-white)were treatad in a double-blind,randomized
mannerforsixmonthswitheitherramiprfl(upto20 mg)orhydrochlorothiazide
(HCTZ;upto60mg).EchoCardiographyandambulatoryBPmonitoringwere
performedat baselineand3 and6 monthsafterinitiationof therapy.The22
ramiprtlpatientswerecomparabletothe26HCTZpatientsatbaselineinage,
race,24-hourBPandLVmassindexbutweremorelikelyto be women(41
vs14%,p < 0.05).AlthoughHCTZresultedina greaterreductionin24-hour
BP(145/93to 132E4vs153A36to147/91mmHg;-9.1/–9.1 vs -3.2!-4.7%
change,p < 0.05),onlytreatmentwith ramiprilresultedin decreasesin LV
mass(193to 179,p <0.005, vs 1S4to 162gm,NS),massindex(103.6to
94.9,p <0.001,vs92.7t091.9gWm2,NS)andmasa/heigh~7(48.5t044.8,
p <0.005, vs41.1to 40.9grn/m27,NS.LVmassdecreasewasattributable
to a reductionin wallthicknessesbutnot chamberdiameter.In multivariate
analysis,bothchangein BPanddruggroupwereindependentpredictors(p
< 0.03)of changein LVmass.
In conclusion,althoughdiuretictherapywassignificantlymoreeffective
in loweringambulatoryBPin this predominantlynon-whitepopulation,only
therapywithACEinhibitionwasassociatedwithsignificantregressionof LV
mass.
